Apogee Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $34.34-$133.87 |
Market Cap | $10B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.33 |
News
See moreYahoo Finance • 3 days ago
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?
Yahoo Finance • 12 days ago
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
Yahoo Finance • 15 days ago
AbbVie (ABBV) Wins Health Canada Approval for Boey
Yahoo Finance • 15 days ago
AbbVie (ABBV) to Acquire Apogee Therapeutics
About
CEO | Dr. Michael Thomas Henderson M.D. |
Address | Building 17, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 261 |